ОбзорГрафикНовостиTraderScreen

UBS Knock-Out QIA/  DE000UM2A7M5  /

UBS Investment Bank
15.11.2024  21:54:45 Изменение-0.100 Бид- Предложение- Базовый актив Цена исполнения Дата истечения Тип опциона
1.030EUR -8.85% -
Величина цены спроса: -		 -
Величина цены предложения: -		 QIAGEN NV 29.0618 EUR 31.12.2078 Call
GlobeNewswire 28.08 QIAGEN expands QIAstat-Dx into precision medicine through partnership for companion diagnostics in c...
TeleTrader 26.08 Europe closes mixed amid Middle East crisis
GlobeNewswire 31.07 QIAGEN delivers solid performance and exceeds outlook for Q2 2024
GlobeNewswire 31.07 Elutia Appoints Ryan Marques, Ph.D., MBA as Vice President of Operations
GlobeNewswire 08.07 QIAGEN to enhance the identification of human remains of Indigenous people and African Americans
GlobeNewswire 02.07 QIAGEN N.V. to release results for Q2 2024 and hold webcast
GlobeNewswire 27.06 QIAGEN welcomes new U.S. guidelines for use of QuantiFERON-TB Gold Plus in detecting tuberculosis in...
GlobeNewswire 17.06 QIAGEN announces 2028 strategy for solid profitable growth
GlobeNewswire 13.06 QIAGEN’s software QCI Interpret accelerates clinical reporting turnaround time for high throughput N...
GlobeNewswire 12.06 QIAGEN publishes 2023 sustainability report, highlighting progress on ESG goals and commitment to su...
GlobeNewswire 11.06 QIAGEN launches new QIAcuity digital PCR assays for microbial applications, enhancing infectious dis...
GlobeNewswire 06.06 QIAGEN to discontinue NeuMoDx integrated PCR testing system, support customers during transition per...
GlobeNewswire 05.06 QIAGEN launches digital PCR Assay Design Tool for QIAcuity, expands customization capabilities of it...
GlobeNewswire 03.06 QIAGEN expands QIAstat-Dx syndromic testing menu in the U.S. with launch of molecular test to improv...
GlobeNewswire 30.05 QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global...
GlobeNewswire 30.05 QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global...
GlobeNewswire 29.05 QIAGEN launches new library preparation kit, facilitating multiomic studies and advancing precision ...
GlobeNewswire 22.05 deepull appoints Didier Deltort to its Board of Directors
GlobeNewswire 14.05 QIAGEN receives European IVDR certification for QIAGEN Clinical Insight Interpret, its medical devic...
GlobeNewswire 13.05 QIAGEN receives FDA clearance for QIAstat-Dx respiratory syndromic testing panel for fast and accura...
GlobeNewswire 07.05 QIAGEN partners with FBI to develop digital PCR assay for QIAcuity for use in forensics
GlobeNewswire 07.05 Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq
GlobeNewswire 07.05 Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq
GlobeNewswire 02.05 QIAGEN enhances bioinformatics workflows with new secondary analysis solution for oncology and inher...
GlobeNewswire 29.04 QIAGEN reports results for Q1 2024 ahead of outlook, on track to achieve full-year 2024 guidance